148 related articles for article (PubMed ID: 34609622)
1. A plasma fatty acid profile associated to type 2 diabetes development: from the CORDIOPREV study.
Villasanta-Gonzalez A; Alcala-Diaz JF; Vals-Delgado C; Arenas AP; Cardelo MP; Romero-Cabrera JL; Rodriguez-Cantalejo F; Delgado-Lista J; Malagon MM; Perez-Martinez P; Schulze MB; Camargo A; Lopez-Miranda J
Eur J Nutr; 2022 Mar; 61(2):843-857. PubMed ID: 34609622
[TBL] [Abstract][Full Text] [Related]
2. Plasma lipidic fingerprint associated with type 2 diabetes in patients with coronary heart disease: CORDIOPREV study.
Villasanta-Gonzalez A; Mora-Ortiz M; Alcala-Diaz JF; Rivas-Garcia L; Torres-Peña JD; Lopez-Bascon A; Calderon-Santiago M; Arenas-Larriva AP; Priego-Capote F; Malagon MM; Eichelmann F; Perez-Martinez P; Delgado-Lista J; Schulze MB; Camargo A; Lopez-Miranda J
Cardiovasc Diabetol; 2023 Aug; 22(1):199. PubMed ID: 37537576
[TBL] [Abstract][Full Text] [Related]
3. Postprandial endotoxemia may influence the development of type 2 diabetes mellitus: From the CORDIOPREV study.
Camargo A; Jimenez-Lucena R; Alcala-Diaz JF; Rangel-Zuñiga OA; Garcia-Carpintero S; Lopez-Moreno J; Blanco-Rojo R; Delgado-Lista J; Perez-Martinez P; van Ommen B; Malagon MM; Ordovas JM; Perez-Jimenez F; Lopez-Miranda J
Clin Nutr; 2019 Apr; 38(2):529-538. PubMed ID: 29685478
[TBL] [Abstract][Full Text] [Related]
4. An altered microbiota pattern precedes Type 2 diabetes mellitus development: From the CORDIOPREV study.
Vals-Delgado C; Alcala-Diaz JF; Molina-Abril H; Roncero-Ramos I; Caspers MPM; Schuren FHJ; Van den Broek TJ; Luque R; Perez-Martinez P; Katsiki N; Delgado-Lista J; Ordovas JM; van Ommen B; Camargo A; Lopez-Miranda J
J Adv Res; 2022 Jan; 35():99-108. PubMed ID: 35024196
[TBL] [Abstract][Full Text] [Related]
5. MiRNAs profile as biomarkers of nutritional therapy for the prevention of type 2 diabetes mellitus: From the CORDIOPREV study.
Jimenez-Lucena R; Alcala-Diaz JF; Roncero-Ramos I; Lopez-Moreno J; Camargo A; Gomez-Delgado F; Quintana-Navarro GM; Vals-Delgado C; Rodriguez-Cantalejo F; Luque RM; Delgado-Lista J; Ordovas JM; Perez-Martinez P; Rangel-Zuñiga OA; Lopez-Miranda J
Clin Nutr; 2021 Mar; 40(3):1028-1038. PubMed ID: 32723508
[TBL] [Abstract][Full Text] [Related]
6. Prediabetes diagnosis criteria, type 2 diabetes risk and dietary modulation: The CORDIOPREV study.
Roncero-Ramos I; Alcala-Diaz JF; Rangel-Zuñiga OA; Gomez-Delgado F; Jimenez-Lucena R; García-Rios A; Vals-Delgado C; Romero-Baldonado C; Luque RM; Ordovas JM; Perez-Martinez P; Camargo A; Lopez-Miranda J
Clin Nutr; 2020 Feb; 39(2):492-500. PubMed ID: 30852029
[TBL] [Abstract][Full Text] [Related]
7. Association between cholesterol efflux capacity and peripheral artery disease in coronary heart disease patients with and without type 2 diabetes: from the CORDIOPREV study.
Yubero-Serrano EM; Alcalá-Diaz JF; Gutierrez-Mariscal FM; Arenas-de Larriva AP; Peña-Orihuela PJ; Blanco-Rojo R; Martinez-Botas J; Torres-Peña JD; Perez-Martinez P; Ordovas JM; Delgado-Lista J; Gómez-Coronado D; Lopez-Miranda J
Cardiovasc Diabetol; 2021 Mar; 20(1):72. PubMed ID: 33766036
[TBL] [Abstract][Full Text] [Related]
8. Biomarkers for Early Diagnostic of Mild Cognitive Impairment in Type-2 Diabetes Patients: A Multicentre, Retrospective, Nested Case-Control Study.
Xu ZP; Yang SL; Zhao S; Zheng CH; Li HH; Zhang Y; Huang RX; Li MZ; Gao Y; Zhang SJ; Zhan PY; Zhang LF; Deng L; Wei S; Liu YC; Ye JW; Ren HJ; Li N; Kong CX; Wang X; Fang L; Zhou QZ; Jiang HW; Li JR; Wang Q; Ke D; Liu GP; Wang JZ
EBioMedicine; 2016 Mar; 5():105-13. PubMed ID: 27077117
[TBL] [Abstract][Full Text] [Related]
9. A plasma circulating miRNAs profile predicts type 2 diabetes mellitus and prediabetes: from the CORDIOPREV study.
Jiménez-Lucena R; Camargo A; Alcalá-Diaz JF; Romero-Baldonado C; Luque RM; van Ommen B; Delgado-Lista J; Ordovás JM; Pérez-Martínez P; Rangel-Zúñiga OA; López-Miranda J
Exp Mol Med; 2018 Dec; 50(12):1-12. PubMed ID: 30598522
[TBL] [Abstract][Full Text] [Related]
10. Association of Lipoproteins, Insulin Resistance, and Rosuvastatin With Incident Type 2 Diabetes Mellitus : Secondary Analysis of a Randomized Clinical Trial.
Dugani SB; Akinkuolie AO; Paynter N; Glynn RJ; Ridker PM; Mora S
JAMA Cardiol; 2016 May; 1(2):136-45. PubMed ID: 27347563
[TBL] [Abstract][Full Text] [Related]
11. Hepatic insulin resistance both in prediabetic and diabetic patients determines postprandial lipoprotein metabolism: from the CORDIOPREV study.
Leon-Acuña A; Alcala-Diaz JF; Delgado-Lista J; Torres-Peña JD; Lopez-Moreno J; Camargo A; Garcia-Rios A; Marin C; Gomez-Delgado F; Caballero J; Van-Ommen B; Malagon MM; Perez-Martinez P; Lopez-Miranda J
Cardiovasc Diabetol; 2016 Apr; 15():68. PubMed ID: 27095446
[TBL] [Abstract][Full Text] [Related]
12. High-sensitivity troponin I and B-type natriuretic peptide biomarkers for prediction of cardiovascular events in patients with coronary artery disease with and without diabetes mellitus.
Wong YK; Cheung CYY; Tang CS; Hai JSH; Lee CH; Lau KK; Au KW; Cheung BMY; Sham PC; Xu A; Lam KSL; Tse HF
Cardiovasc Diabetol; 2019 Dec; 18(1):171. PubMed ID: 31847896
[TBL] [Abstract][Full Text] [Related]
13. Biomarkers of fatty acids and risk of type 2 diabetes: a systematic review and meta-analysis of prospective cohort studies.
Chen G; Li Y; Zeng F; Deng G; Liang J; Wang J; Su Y; Chen Y; Mao L; Liu Z; Bao W; Zhang Z
Crit Rev Food Sci Nutr; 2021; 61(16):2705-2718. PubMed ID: 32598176
[TBL] [Abstract][Full Text] [Related]
14. Comparison of plasma and erythrocyte membrane fatty acid compositions in patients with end-stage renal disease and type 2 diabetes mellitus.
Sertoglu E; Kurt I; Tapan S; Uyanik M; Serdar MA; Kayadibi H; El-Fawaeir S
Chem Phys Lipids; 2014 Feb; 178():11-7. PubMed ID: 24384240
[TBL] [Abstract][Full Text] [Related]
15. Increasing the proportion of plasma MUFA, as a result of dietary intervention, is associated with a modest improvement in insulin sensitivity.
Johns I; Frost G; Dornhorst A
J Nutr Sci; 2019 Nov; 9():e6. PubMed ID: 32076549
[TBL] [Abstract][Full Text] [Related]
16. Insulin secretagogues for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus.
Hemmingsen B; Sonne DP; Metzendorf MI; Richter B
Cochrane Database Syst Rev; 2016 Oct; 10(10):CD012151. PubMed ID: 27749986
[TBL] [Abstract][Full Text] [Related]
17. Fatty acid quality and quantity of diet and risk of type 2 diabetes in adults: Tehran Lipid and Glucose Study.
Mirmiran P; Esfandyari S; Moghadam SK; Bahadoran Z; Azizi F
J Diabetes Complications; 2018 Jul; 32(7):655-659. PubMed ID: 29853261
[TBL] [Abstract][Full Text] [Related]
18. Lipoprotein insulin resistance index, a high-throughput measure of insulin resistance, is associated with incident type II diabetes mellitus in the Prevention of Renal and Vascular End-Stage Disease study.
Flores-Guerrero JL; Connelly MA; Shalaurova I; Gruppen EG; Kieneker LM; Dullaart RPF; Bakker SJL
J Clin Lipidol; 2019; 13(1):129-137.e1. PubMed ID: 30591414
[TBL] [Abstract][Full Text] [Related]
19. Metabolomics analysis of type 2 diabetes remission identifies 12 metabolites with predictive capacity: a CORDIOPREV clinical trial study.
Mora-Ortiz M; Alcala-Diaz JF; Rangel-Zuñiga OA; Arenas-de Larriva AP; Abollo-Jimenez F; Luque-Cordoba D; Priego-Capote F; Malagon MM; Delgado-Lista J; Ordovas JM; Perez-Martinez P; Camargo A; Lopez-Miranda J
BMC Med; 2022 Oct; 20(1):373. PubMed ID: 36289459
[TBL] [Abstract][Full Text] [Related]
20. Association of plasma free fatty acids levels with the presence and severity of coronary and carotid atherosclerotic plaque in patients with type 2 diabetes mellitus.
Zhang MH; Cao YX; Wu LG; Guo N; Hou BJ; Sun LJ; Guo YL; Wu NQ; Dong Q; Li JJ
BMC Endocr Disord; 2020 Oct; 20(1):156. PubMed ID: 33087077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
